Mark Neumann
Corporate Officer/Principal at INTRA-CELLULAR THERAPIES, INC.
Net worth: 2 M $ as of 30/03/2024
Profile
Mark Neumann is currently the Chief Commercial Officer & Executive VP at Intra-Cellular Therapies, Inc. Prior to his current position, he served as the Vice President-Global Marketing at Amgen, Inc. from 2016 to 2018.
Before that, he held the position of Vice President-Global Commercialization at Bristol Myers Squibb Co. from 2008 to 2014.
Mr. Neumann completed his undergraduate degree at Lafayette College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/03/2024 | 29,700 ( 0.03% ) | 2 M $ | 30/03/2024 |
Mark Neumann active positions
| Companies | Position | Start |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Corporate Officer/Principal | 15/10/2018 |
Former positions of Mark Neumann
| Companies | Position | End |
|---|---|---|
| AMGEN INC. | Sales & Marketing | 31/08/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 30/04/2014 |
Training of Mark Neumann
| Lafayette College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
- Stock Market
- Insiders
- Mark Neumann
